FDA denies Vanda's Tradipitant application for gastroparesis, urging new trials for efficacy and safety. Vanda disputes the ...

Bhopal: Nidhi Singh, additional commissioner of Bhopal Municipal Corporation, was transferred to joint commissioner land records, Gwalior.

Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, announced today that Dr ...

SpringWorks has shown strong revenue growth with OGSIVEO, achieving a 23% increase from Q2 of 2024 to Q3 of 2024. See why I ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review. As ...

The FDA has accepted for filing and priority review Sentynl Therapeutics’ CUTX-101 NDA for the treatment of Menkes disease.

When the principal secretary was involved in the process and the CMO too knew ... Is the conspirator from the NDA or the Opposition? Because the MLA you are referring to is from the SP. Did that MLA ...

“Similar participation in the process is seen in primates,” Gaydos ... Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs ...

Shares of Verastem Oncology VSTM rallied 40.9% on Tuesday after it announced that the FDA has accepted the new drug application (NDA) for its avutometinib/defactinib ...

Highlights,FDA grants Priority Review for new treatment combination in recurrent KRAS mutant LGSOC.,Phase 2 trial results show promising response rates for avutometinib and defactinib.,First potential ...

“With the acceptance of this NDA, we’re taking an important step forward in addressing a condition that has long been overlooked, and we look forward to working with the FDA during its review process ...